Cargando…
Newly developed 3D in vitro models to study tumor–immune interaction
Immunotherapy as a rapidly developing therapeutic approach has revolutionized cancer treatment and revitalized the field of tumor immunology research. 3D in vitro models are emerging as powerful tools considering their feature to maintain tumor cells in a near-native state and have been widely appli...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074642/ https://www.ncbi.nlm.nih.gov/pubmed/37016422 http://dx.doi.org/10.1186/s13046-023-02653-w |
_version_ | 1785019780204331008 |
---|---|
author | Mu, Peiyuan Zhou, Shujuan Lv, Tao Xia, Fan Shen, Lijun Wan, Juefeng Wang, Yaqi Zhang, Hui Cai, Sanjun Peng, Junjie Hua, Guoqiang Zhang, Zhen |
author_facet | Mu, Peiyuan Zhou, Shujuan Lv, Tao Xia, Fan Shen, Lijun Wan, Juefeng Wang, Yaqi Zhang, Hui Cai, Sanjun Peng, Junjie Hua, Guoqiang Zhang, Zhen |
author_sort | Mu, Peiyuan |
collection | PubMed |
description | Immunotherapy as a rapidly developing therapeutic approach has revolutionized cancer treatment and revitalized the field of tumor immunology research. 3D in vitro models are emerging as powerful tools considering their feature to maintain tumor cells in a near-native state and have been widely applied in oncology research. The novel 3D culture methods including the co-culture of organoids and immune cells, ALI culture, 3D-microfluidic culture and 3D-bioprinting offer new approaches for tumor immunology study and can be applied in many fields such as personalized treatment, immunotherapy optimizing and adoptive cell therapy. In this review, we introduce commonly used 3D in vitro models and summarize their applications in different aspects of tumor immunology research. We also provide a preliminary analysis of the current shortcomings of these models and the outlook of future development. |
format | Online Article Text |
id | pubmed-10074642 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-100746422023-04-06 Newly developed 3D in vitro models to study tumor–immune interaction Mu, Peiyuan Zhou, Shujuan Lv, Tao Xia, Fan Shen, Lijun Wan, Juefeng Wang, Yaqi Zhang, Hui Cai, Sanjun Peng, Junjie Hua, Guoqiang Zhang, Zhen J Exp Clin Cancer Res Review Immunotherapy as a rapidly developing therapeutic approach has revolutionized cancer treatment and revitalized the field of tumor immunology research. 3D in vitro models are emerging as powerful tools considering their feature to maintain tumor cells in a near-native state and have been widely applied in oncology research. The novel 3D culture methods including the co-culture of organoids and immune cells, ALI culture, 3D-microfluidic culture and 3D-bioprinting offer new approaches for tumor immunology study and can be applied in many fields such as personalized treatment, immunotherapy optimizing and adoptive cell therapy. In this review, we introduce commonly used 3D in vitro models and summarize their applications in different aspects of tumor immunology research. We also provide a preliminary analysis of the current shortcomings of these models and the outlook of future development. BioMed Central 2023-04-04 /pmc/articles/PMC10074642/ /pubmed/37016422 http://dx.doi.org/10.1186/s13046-023-02653-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Mu, Peiyuan Zhou, Shujuan Lv, Tao Xia, Fan Shen, Lijun Wan, Juefeng Wang, Yaqi Zhang, Hui Cai, Sanjun Peng, Junjie Hua, Guoqiang Zhang, Zhen Newly developed 3D in vitro models to study tumor–immune interaction |
title | Newly developed 3D in vitro models to study tumor–immune interaction |
title_full | Newly developed 3D in vitro models to study tumor–immune interaction |
title_fullStr | Newly developed 3D in vitro models to study tumor–immune interaction |
title_full_unstemmed | Newly developed 3D in vitro models to study tumor–immune interaction |
title_short | Newly developed 3D in vitro models to study tumor–immune interaction |
title_sort | newly developed 3d in vitro models to study tumor–immune interaction |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074642/ https://www.ncbi.nlm.nih.gov/pubmed/37016422 http://dx.doi.org/10.1186/s13046-023-02653-w |
work_keys_str_mv | AT mupeiyuan newlydeveloped3dinvitromodelstostudytumorimmuneinteraction AT zhoushujuan newlydeveloped3dinvitromodelstostudytumorimmuneinteraction AT lvtao newlydeveloped3dinvitromodelstostudytumorimmuneinteraction AT xiafan newlydeveloped3dinvitromodelstostudytumorimmuneinteraction AT shenlijun newlydeveloped3dinvitromodelstostudytumorimmuneinteraction AT wanjuefeng newlydeveloped3dinvitromodelstostudytumorimmuneinteraction AT wangyaqi newlydeveloped3dinvitromodelstostudytumorimmuneinteraction AT zhanghui newlydeveloped3dinvitromodelstostudytumorimmuneinteraction AT caisanjun newlydeveloped3dinvitromodelstostudytumorimmuneinteraction AT pengjunjie newlydeveloped3dinvitromodelstostudytumorimmuneinteraction AT huaguoqiang newlydeveloped3dinvitromodelstostudytumorimmuneinteraction AT zhangzhen newlydeveloped3dinvitromodelstostudytumorimmuneinteraction |